Ep. 43: “Respiratory Viral Infections” Featuring Dr. Jie Sun
Dec 6, 2022
auto_awesome
Dr. Jie Sun, a professor at the University of Virginia specializing in respiratory immunology and long COVID, dives into the intricate world of respiratory viral infections. He compares long COVID with other post-viral conditions while elucidating his lab's groundbreaking research on mucosal immunity from mRNA vaccines. The conversation also highlights emerging strategies for enhancing immunity against evolving strains, alongside the pressing public health implications of recent viral surges, including the complex challenges posed by long-term health effects.
Dr. Jie Sun emphasizes the significance of understanding immune responses to respiratory viral infections and their long-term health implications.
The podcast highlights the evolution of knowledge regarding COVID-19 and its impact on public health, especially concerning other respiratory viruses.
Dr. Sun advocates for exploring nasal vaccination strategies to improve mucosal immunity, which is crucial for effectively combating respiratory pathogens.
Deep dives
Research on Respiratory Immunology
Dr. Jia Sun discusses his research in respiratory immunology, focusing on immune responses to viral infections. He emphasizes the need for a better understanding of how the immune system reacts to both the initial viral infection and the subsequent chronic conditions that can arise. Specific attention is given to the relationship between acute infections and the long-term implications for immune health, highlighting the vital role of respiratory viral pathogenesis. The conversation underscores the importance of ongoing studies to uncover the mechanisms that underpin the immune system's behavior in both homeostatic and diseased states.
Challenges in Current Approaches to COVID-19
The podcast delves into the challenges posed by COVID-19 and its long-term consequences on public health. Dr. Sun reflects on the rapid evolution of knowledge in the field, which has been essential for developing effective vaccines and treatments. He also mentions concerns regarding other persistent respiratory viruses, such as influenza and RSV, and how these have emerged as public health threats alongside COVID-19. This highlights the importance of integrating learnings from COVID-19 research into understanding and managing other respiratory infections.
Mucosal Immunity and Vaccination Strategies
The discussion emphasizes the significance of mucosal immunity in the context of respiratory viral infections. Dr. Sun reveals findings that illustrate how traditional vaccinations may not adequately induce strong mucosal immune responses compared to natural infections. He advocates for exploring nasal vaccination strategies to enhance mucosal IgA responses, which are critical for blocking initial viral entry. This hints at the potential benefits of creating vaccines that can effectively target mucosal surfaces to improve the body's defense against respiratory pathogens.
Age-Related Changes in Immune Response
Dr. Sun discusses how aging impacts the immune system's response to viral infections, particularly in the respiratory tract. With age, the immune response becomes slower and less effective, increasing susceptibility to infections and the likelihood of poor recovery outcomes. He explains that older individuals might experience prolonged inflammation, leading to greater tissue damage and impaired healing. This aspect of immunology highlights the need for tailored interventions for elderly populations to improve their resilience to respiratory infections.
Innovations in Tumor Immunotherapy
The podcast covers innovative approaches to cancer treatment through immunotherapy, specifically enhancing the function of dendritic cells alongside oncolytic virus therapy. Dr. Sun elaborates on a study combining FLT3 ligand treatment with Newcastle disease virus to improve tumor antigen presentation and T-cell activation in mouse models. This synergistic approach shows promise for stronger anti-tumor responses and long-term immunity against various cancers. The exploration of these cutting-edge strategies reflects the evolving landscape of immunotherapeutic techniques in oncology.
Dr. Jie Sun is the Harrison Professor of Medicine at the University of Virginia. His lab studies respiratory immunology under homeostasis and disease conditions. He talks about how long COVID compares to other post-viral conditions, and his lab’s work investigating mucosal immunity from mRNA vaccines.
Cardiac Autoimmunity – C-Met+ T cells are selectively increased in the circulation and in the myocardium of patients with inflammatory cardiomyopathies.
A Universal Flu Vaccine – Scientists developed an mRNA–lipid nanoparticle vaccine encoding hemagglutinin antigens from all 20 known influenza A virus subtypes and influenza B virus lineages.
mRNA Export Rates and Gene Expression – The nuclear export efficiency of innate immune mRNAs varies such that for many genes, only a small fraction of the newly synthesized pre-mRNA reaches the cytoplasm.
!
